Literature DB >> 11166924

Protein deimination in the rat brain after kainate administration: citrulline-containing proteins as a novel marker of neurodegeneration.

H Asaga1, A Ishigami.   

Abstract

Peptidylarginine deiminases (PADs) are a group of enzymes that convert protein arginine residues to citrulline residues in a Ca2+-dependent manner. In the central nervous system, PAD type II localizes in glial cells, but its biological role is little understood. We examined the timing and region dependence of protein deimination in the rat cerebrum after a systemic injection of kainic acid (KA). Citrulline-containing proteins were consistently found in neurodegenerating regions. Western blot analyses showed deimination of numerous proteins in a broad-molecular-weight range. By immunocytochemical scrutiny, deiminated protein-positive astrocytes were found at 2 h after KA administration, and they increased in number until the 6 h. Furthermore, shrunken neurons became deiminated protein-positive at 12-24 h. These data suggest that PAD type II becomes activated in regions undergoing neurodegeneration and functions to deiminate various proteins. Therefore, citrulline-containing proteins seem to be a useful marker of acute neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11166924     DOI: 10.1016/s0304-3940(00)01735-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

1.  Peptidylarginine deiminase 4: a nuclear button triggering neutrophil extracellular traps in inflammatory diseases and aging.

Authors:  Siu Ling Wong; Denisa D Wagner
Journal:  FASEB J       Date:  2018-06-20       Impact factor: 5.191

2.  Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis.

Authors:  Byungki Jang; Eunah Kim; Jin-Kyu Choi; Jae-Kwang Jin; Jae-Il Kim; Akihito Ishigami; Naoki Maruyama; Richard I Carp; Yong-Sun Kim; Eun-Kyoung Choi
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

Review 3.  Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis.

Authors:  Shu Wang; Yanming Wang
Journal:  Biochim Biophys Acta       Date:  2013-07-13

Review 4.  Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.

Authors:  Lei Yang; Dewei Tan; Hua Piao
Journal:  Neurochem Res       Date:  2016-04-21       Impact factor: 3.996

5.  Retinal deimination and PAD2 levels in retinas from donors with age-related macular degeneration (AMD).

Authors:  Vera L Bonilha; Karen G Shadrach; Mary E Rayborn; Yong Li; Gayle J T Pauer; Stephanie A Hagstrom; Sanjoy K Bhattacharya; Joe G Hollyfield
Journal:  Exp Eye Res       Date:  2013-04-03       Impact factor: 3.467

6.  Age-related reduction in retinal deimination levels in the F344BN rat.

Authors:  Sanjoy K Bhattacharya; Brent Sinicrope; Mary E Rayborn; Joe G Hollyfield; Vera L Bonilha
Journal:  Aging Cell       Date:  2008-01-31       Impact factor: 9.304

7.  Citrullinated inter-alpha-trypsin inhibitor heavy chain 4 in arthritic joints and its potential effect in the neutrophil migration.

Authors:  A Osada; I Matsumoto; N Mikami; A Ohyama; I Kurata; Y Kondo; H Tsuboi; A Ishigami; Y Sano; T Arai; N Ise; T Sumida
Journal:  Clin Exp Immunol       Date:  2020-12-20       Impact factor: 5.732

Review 8.  Roles of B cells in rheumatoid arthritis.

Authors:  Gregg J Silverman; Dennis A Carson
Journal:  Arthritis Res Ther       Date:  2003-12-02       Impact factor: 5.156

9.  Is anti-cyclic citrullinated Peptide antibody a good value biomarker for Alzheimer disease?

Authors:  Rokhsareh Meamar; Gholamreza Askari; Majid Ghasemi; Mohammad Reza Aghaye Ghazvini; Sahar Vesal; Mostafa Sharifkhah; Nazanin Alaei Faradonbeh; Leila Dehghani
Journal:  Int J Prev Med       Date:  2013-05

10.  Protein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury.

Authors:  Rachel C Lazarus; John E Buonora; Michael N Flora; James G Freedy; Gay R Holstein; Giorgio P Martinelli; David M Jacobowitz; Gregory P Mueller
Journal:  Front Neurol       Date:  2015-09-22       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.